Cassava Sciences Invited to Participate in B. Riley Securities’ Neuroscience Conference
Cassava Sciences, Inc. (Nasdaq: SAVA) will participate in the B. Riley Securities’ Neuroscience Conference on April 28-29, 2021.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Cassava Sciences, Inc. (Nasdaq: SAVA) will participate in the B. Riley Securities’ Neuroscience Conference on April 28-29, 2021. Remi Barbier, President & CEO, is set to engage in a virtual Fireside Chat on April 28 at 2:30 PM Eastern. The conference will address topics in neurodegeneration and neuropsychiatry, featuring prominent companies in the field. An archived replay of the chat will be available on Cassava's website for about 90 days post-event. For details, visit CassavaSciences.com.
Details
News Market Reaction – SAVA
The recorded move for SAVA in the trading session of this news was +6.05%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Fireside Chat on Wednesday, April 28th at 2:30PM Eastern
AUSTIN, Texas, April 27, 2021 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer’s disease, today announced that it has been invited to participate in the B. Riley Securities’ Neuroscience Conference, a virtual event taking place on April 28-29, 2021. The B. Riley Securities' Neuroscience Conference will cover key topics across neurodegeneration and neuropsychiatry disease areas with leading companies in the field.
Remi Barbier, President & CEO, will participate in a virtual Fireside Chat led by the research team at B. Riley Securities on Wednesday, April 28, 2021 at 2:30 PM – 3:00 PM Eastern time. The link for this webcast is: https://www.webcaster4.com/Webcast/Page/2433/41052. An archived replay of the Fireside Chat will be available on Cassava Sciences’ website for approximately 90 days following the event.
About Cassava Sciences, Inc.
Cassava Sciences’ mission is to discover and develop innovations for chronic, neurodegenerative conditions. Over the past 10 years, Cassava Sciences has combined state-of-the-art technology with new insights in neurobiology to develop novel solutions for Alzheimer’s disease. For more information, please visit: https://www.CassavaSciences.com.
For More Information Contact:
Eric Schoen, Chief Financial Officer
eschoen@CassavaSciences.com
(512) 501-2450
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.